Skip to main content
Wanbury Limited logo

Wanbury Limited — Investor Relations & Filings

Ticker · WANBURY ISIN · INE107F01022 LEI · 335800QB384KGMBID276 BSE.NS Manufacturing
Open in API
Filings indexed 916 across all filing types
Latest filing 2020-02-14 Regulatory Filings
Country IN India
Listing BSE.NS WANBURY

About Wanbury Limited

https://www.wanbury.com

Wanbury Limited specializes in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and finished formulations. The organization maintains a significant global presence, particularly as a leading producer of Metformin. Its product portfolio spans diverse therapeutic areas, including gynecology, orthopedics, hematinics, and anti-diabetics. The company operates manufacturing facilities compliant with international regulatory standards, including the USFDA. Wanbury focuses on providing medicinal solutions through integrated research and development capabilities and large-scale production infrastructure, serving both domestic and international markets with a range of specialty products.

Recent filings

Filing Released Lang Actions
Financial Result Updates
Regulatory Filings
2020-02-14 English
Outcome of Board Meeting
Interim / Quarterly Report Classification · 95% confidence The document is a formal communication from Wanbury Limited to stock exchanges (BSE and NSE) dated 14th February 2020. It announces the outcome of a Board Meeting held on the same day. The key points include: appointment of an additional director, approval of standalone and consolidated un-audited financial results for the third quarter and nine months ended 31st December 2019, allotment of equity shares upon exercise of employee stock options, and increase in paid-up share capital. The document also encloses the financial results and a limited review report as per SEBI regulations. The presence of un-audited financial results for a quarter and nine months indicates this is an Interim / Quarterly Report. The document is detailed (15,000 characters) and contains substantive financial data, not merely an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2020-02-14 English
i) Appointment of Ms. Pallavi Shedge (DIN: 08356412) . ii) Standalone & Consolidated Un-audited Financial Results (UFR) of the Company as per Indian Accounting Standards (IndAS) for ....
Regulatory Filings
2020-02-14 English
Updates
Capital/Financing Update Classification · 95% confidence The document is an official communication addressed to stock exchanges (BSE and NSE) regarding a transaction completed by the company Wanbury Limited. It references Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations (LODR), which mandates disclosure of material events. The content details the sale of certain brands to Cipla Limited, including financial figures, dates, and transaction specifics. This is a disclosure about a capital transaction rather than a full financial report or earnings release. The document is relatively short (4349 characters) and serves as an update on a financing/capital event. Therefore, it fits best under the category 'Capital/Financing Update' (CAP).
2020-02-08 English
Pursuant to Regulation 30 of the LODR, and further to our letter dated 20th September, 2019, we wish to inform you that the Company has concluded the transaction with Cipla Limited by ....
Regulatory Filings
2020-02-08 English
Board Meeting — Financial Results
Regulatory Filings Classification · 90% confidence The document text contains only placeholders for images and no textual content or financial data. The true document length is only 171 characters, indicating it is extremely short and does not contain any substantive report or announcement text. There is no indication of any report, announcement, or filing type. Given the lack of content, the document cannot be classified as a report or announcement and falls under the fallback category of Regulatory Filings (RNS).
2020-02-05 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.